Physicochemical modifications of histones and their impact on epigenomics (English)
- New search for: Andreoli, F.
- New search for: Del Rio, A.
- New search for: Andreoli, F.
- New search for: Del Rio, A.
In:
DRUG DISCOVERY TODAY
;
19
, 9
;
1372-1379
;
2014
-
ISSN:
- Article (Journal) / Print
-
Title:Physicochemical modifications of histones and their impact on epigenomics
-
Contributors:Andreoli, F. ( author ) / Del Rio, A. ( author )
-
Published in:DRUG DISCOVERY TODAY ; 19, 9 ; 1372-1379
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2014-01-01
-
Size:8 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 615.1
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 615.1 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 19, Issue 9
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1279
-
Minding the gaps in tuberculosis researchEkins, S. / Nuermberger, E. L. / Freundlich, J. S. et al. | 2014
- 1283
-
An analysis of FDA-approved drugs for infectious disease: antibacterial agentsKinch, M. S. / Patridge, E. / Plummer, M. / Hoyer, D. et al. | 2014
- 1288
-
Enabled clinical use of an HIV-1 attachment inhibitor through drug deliveryTimmins, P. / Brown, J. / Meanwell, N. A. / Hanna, G. J. / Zhu, L. / Kadow, J. F. et al. | 2014
- 1294
-
Safety information on QT-interval prolongation: comparison of European Union and United States drug labelingWarnier, M. J. / Holtkamp, F. A. / Rutten, F. H. / Hoes, A. W. / de Boer, A. / Mol, P. G. / De Bruin, M. L. et al. | 2014
- 1298
-
Small-molecule clinical trial candidates for the treatment of gliomaPrabhu, S. / Harris, F. / Lea, R. / Snape, T. J. et al. | 2014
- 1309
-
Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseasesKanwar, J. R. / Shankaranarayanan, J. S. / Gurudevan, S. / Kanwar, R. K. et al. | 2014
- 1322
-
A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentalsDebotton, N. / Dahan, A. et al. | 2014
- 1337
-
Delivery of epidrugsel Bahhaj, F. / Dekker, F. J. / Martinet, N. / Bertrand, P. et al. | 2014
- 1353
-
CANDO and the infinite drug discovery frontierMinie, M. / Chopra, G. / Sethi, G. / Horst, J. / White, G. / Roy, A. / Hatti, K. / Samudrala, R. et al. | 2014
- 1364
-
Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case studyQu, X. A. / Freudenberg, J. M. / Sanseau, P. / Rajpal, D. K. et al. | 2014
- 1372
-
Physicochemical modifications of histones and their impact on epigenomicsAndreoli, F. / Del Rio, A. et al. | 2014
- 1380
-
Animal models of invasive aspergillosis for drug discoveryPaulussen, C. / Boulet, G. A. / Cos, P. / Delputte, P. / Maes, L. J. et al. | 2014
- 1387
-
Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathyKwa, F. A. / Thrimawithana, T. R. et al. | 2014
- 1394
-
Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapiesJagessar, S. A. / Kap, Y. S. / Haanstra, K. G. / Philippens, I. H. / Serguera, C. / Langermans, J. / Vierboom, M. et al. | 2014
- 1402
-
Deciphering molecular determinants of chemotherapy in gastrointestinal malignancy using systems biology approachesfor, t. 2. / Lin, L. L. / Huang, H. C. / Juan, H. F. et al. | 2014
- 1410
-
Melatonin: functions and ligandsSingh, M. / Jadhav, H. R. et al. | 2014
- 1419
-
Therapeutic strategies for treating osteolytic bone metastasesVerron, E. / Schmid-Antomarchi, H. / Pascal-Mousselard, H. / Schmid-Alliana, A. / Scimeca, J. C. / Bouler, J. M. et al. | 2014
- 1427
-
Synergizing immunotherapy with molecular-targeted anticancer treatmentFernandez, A. et al. | 2014
- 1433
-
New advances in treating thrombotic diseasesSchumacher, W. A. / Wang, X. / Wong, P. C. et al. | 2014
- 1435
-
Inhibition of Factor XI activity as a promising antithrombotic strategyChen, Z. / Seiffert, D. / Hawes, B. et al. | 2014
- 1440
-
Tissue factor-fVIIa inhibition: update on an unfinished quest for a novel oral antithromboticPriestley, E. S. et al. | 2014
- 1445
-
Factor IXa as a target for anticoagulation in thrombotic disorders and conditionsSmiley, D. A. / Becker, R. C. et al. | 2014
- 1454
-
Factor XI as a target for antithrombotic therapyBane, C. E. / Gailani, D. et al. | 2014
- 1459
-
Factor XII: a drug target for safe interference with thrombosis and inflammationKenne, E. / Renne, T. et al. | 2014
- 1465
-
Reversal of target-specific oral anticoagulantsSiegal, D. M. / Cuker, A. et al. | 2014
- 1471
-
New advances in treating thrombotic diseases: GPVI as a platelet drug targetJiang, P. / Jandrot-Perrus, M. et al. | 2014
- 1476
-
Novel or expanding current targets in fibrinolysisWyseure, T. / Declerck, P. J. et al. | 2014
- 1483
-
Personalizing prostate cancer therapy: the way forwardCetnar, J. P. / Beer, T. M. et al. | 2014
- 1488
-
Sulforaphane and prostate cancer interceptionTraka, M. H. / Melchini, A. / Mithen, R. F. et al. | 2014
- 1493
-
Strategies for targeting the androgen receptor axis in prostate cancerCarver, B. S. et al. | 2014
- 1498
-
The emerging role of speckle-type POZ protein (SPOP) in cancer developmentMani, R. S. et al. | 2014
-
Contents page 1| 2014
-
Content page 2| 2014